NCT07401537

Efficacy and Safety of Extended-Dose Interval Immunotherapy Versus Standard-Dose Interval Immunotherapy for Advanced Triple-Negative Breast Cancer

Public trial-level signal summary for this oncology Phase 2 record.

Record overview

Status and phase

Status: RECRUITING

Phase: PHASE2

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Condition: Triple -Negative Breast Cancer, Breast Cancer

Signal summary

Public flags

Status signal: Low Signal

Timeline signals: None

Results signal: Low Signal

Operational burden: large_enrollment_target_signal | few_sites_large_trial_signal

Stopped reason

Context when available

No stop reason available in the current public record.